Literature DB >> 22237841

Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification.

Alexander Kroiss, Daniel Putzer, Christian Uprimny, Clemens Decristoforo, Michael Gabriel, Wolfram Santner, Christof Kranewitter, Boris Warwitz, Dietmar Waitz, Dorota Kendler, Irene Johanna Virgolini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22237841     DOI： 10.1007/s00259-011-1962-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  1 in total

1.  Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.

Authors:  Alexander Kroiss; Daniel Putzer; Christian Uprimny; Clemens Decristoforo; Michael Gabriel; Wolfram Santner; Christof Kranewitter; Boris Warwitz; Dietmar Waitz; Dorota Kendler; Irene Johanna Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-29       Impact factor: 9.236
  1 in total
  2 in total

Review 1.  123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Authors:  Gitta Bleeker; Godelieve A M Tytgat; Judit A Adam; Huib N Caron; Leontien C M Kremer; Lotty Hooft; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29

2.  Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors.

Authors:  Amir Sabet; James Nagarajah; Ahmet Semih Dogan; Hans-Jürgen Biersack; Amin Sabet; Stefan Guhlke; Samer Ezziddin
Journal:  EJNMMI Res       Date:  2013-12-26       Impact factor: 3.138
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.